SARS-CoV2 infection, recovery and mortality: Insights from multiplexed imaging, proteomics and transcript profiling
Zoltan Maliga, Ph.D., Laboratory of Systems Pharmacology- Harvard Medical School
Zoltan Maliga, Ph.D., Laboratory of Systems Pharmacology- Harvard Medical School
Drew Weissman, M.D., Ph.D., Professor of Medicine- University of Pennsylvania
Bette Korber, M.D., Los Alamos National Laboratory
Nicole Doria-Rose, Ph.D., Staff Scientist, Chief, Humoral Immunology Core, Vaccine Research Center- NIH
Caroline Junqueira, Ph.D., Associate Professor, Oswaldo Cruz Foundation (Fiocruz)-Brazil- Research Associate, Program in Cellular and Molecular Medicine at Boston Children’s Hospital/ Harvard Medical School
Michael R. Betts, Ph.D., Professor, University of PennsylvaniaPerelman School of Medicine, Department of Microbiology. Director, CAMB-MVP Graduate Group
Theodora Hatziioannou, Ph.D., Research Associate Professor- Rockefeller University
Barton F. Haynes, M.D., Director, Duke Human Vaccine Institute, Frederic M. Hanes Professor of Medicine, Professor of Immunology and Global Health- Duke University Medical Center
Galit Alter, Ph.D.- Professor of Medicine- HMS, Group Leader- The Ragon Institute of MGH, MIT and Harvard
Thomas S. Kupper, M.D., Fitzpatrick Professor and Chair, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School